688133.SHG Shanghai Titan Scientific Co. Ltd. A
- Market cap
- CNY 2.89B
- P/E
- -
- P/B
- 1.02x
- ROE
- -3.1%
- Dividend yield
- 1.96%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 688133.SHG undervalued?
Graham numberThe Graham number of Shanghai Titan Scientific Co. Ltd. A cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai Titan Scientific Co. Ltd. A fundamental analysis
No fundamental analysis for Shanghai Titan Scientific Co. Ltd. A yet.
Shanghai Titan Scientific Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai Titan Scientific Co. Ltd. A
Shanghai Titan Scientific Co., Ltd. provides laboratory products and supporting services for scientific researchers and quality control personnel. The company offers scientific research reagents, special chemicals, scientific research instruments and consumables, and laboratory construction and scientific research information services. It serves universities, hospitals, research institutes, government agencies, and R&D companies, as well as biopharmaceutical, pharmaceutical,…
Full company profileShanghai Titan Scientific Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai Titan Scientific Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 409M | 664M | 926M | 1.14B | 1.38B | 2.16B | 2.61B | 2.77B | 2.88B | 2.51B | 2.53B |
| Gross Profit | 96.9M | 148M | 199M | 273M | 293M | 458M | 563M | 576M | 566M | -47.2M | 532M |
| Operating Income | 28.2M | 42.7M | 67.3M | 84.0M | 113M | 171M | 152M | 85.5M | 12.2M | -47.2M | -21.9M |
| EBITDA | 34.4M | 51.4M | 79.0M | 98.6M | 136M | 195M | 209M | 157M | 106M | 29.1M | -55.8M |
| Net Income | 27.5M | 38.6M | 59.9M | 74.1M | 103M | 144M | 125M | 72.6M | 12.9M | -13.0M | -85.4M |
| EPS | 0.63 | 0.83 | 0.61 | 0.71 | 0.87 | 0.96 | 0.81 | 0.44 | 0.08 | -0.08 | -0.52 |
| Balance Sheet | |||||||||||
| Total Assets | 357M | 453M | 655M | 931M | 1.85B | 2.59B | 3.97B | 4.39B | 4.85B | 4.87B | 4.96B |
| Total Liabilities | 158M | 165M | 268M | 368M | 396M | 977M | 1.20B | 1.54B | 1.98B | 2.04B | 2.17B |
| Shareholders' Equity | 199M | 287M | 386M | 564M | 1.44B | 1.58B | 2.72B | 2.79B | 2.79B | 2.75B | 2.71B |
| Cash & Short-term Investments | 88.8M | 106M | 215M | 308M | 874M | 687M | 1.39B | 1.05B | 1.03B | 881M | 812M |
| Total Debt | 60.0M | 64.7M | 122M | 173M | 187M | 465M | 844M | 1.06B | 1.43B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -796K | 16.7M | 34.5M | -31.8M | -138M | -242M | -151M | -125M | 189M | 238M | - |
| Capital Expenditure | 9.17M | 12.2M | 21.8M | 28.9M | 96.6M | 135M | 300M | 465M | 481M | 285M | 211M |
| Free Cash Flow | -9.96M | 4.52M | 12.7M | -60.7M | -235M | -377M | -451M | -589M | -292M | -47.3M | -435M |
| Ratios | |||||||||||
| ROE | 13.8% | 13.4% | 15.5% | 13.2% | 7.1% | 9.1% | 4.6% | 2.6% | 0.5% | -0.5% | -3.1% |
| ROA | 7.7% | 8.5% | 9.2% | 8.0% | 5.6% | 5.6% | 3.1% | 1.7% | 0.3% | -0.3% | -1.7% |
| Net Profit Margin | 6.7% | 5.8% | 6.5% | 6.5% | 7.4% | 6.7% | 4.8% | 2.6% | 0.4% | -0.5% | -3.4% |
| Debt to Equity | 0.30x | 0.23x | 0.32x | 0.31x | 0.13x | 0.29x | 0.31x | 0.38x | 0.51x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai Titan Scientific Co. Ltd. A dividends
- Dividend yield
- 1.96%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 20, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 56.5M | 0.35 | - |
| 2024 | CNY 55.8M | 0.35 | 432.7% |
| 2023 | CNY 47.6M | 0.29 | 65.6% |
| 2022 | CNY 14.7M | 0.10 | 11.8% |
| 2021 | CNY 29.7M | 0.20 | 20.6% |
| 2020 | CNY 8.04M | 0.07 | 7.8% |
| 2019 | CNY 26.4M | 0.25 | 35.6% |
| 2018 | 25.0M | 0.26 | 41.7% |
| 2017 | 23.3M | 0.50 | 60.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jun 21, 2024.
Who owns Shanghai Titan Scientific Co. Ltd. A
- Insiders 31.04%
- Institutions 4.55%
- Public & others 64.41%
- Shares outstanding 164M
- Free float 120M
Shanghai Titan Scientific Co. Ltd. A company profile
- Company name
- Shanghai Titan Scientific Co. Ltd. A
- Ticker
- 688133.SHG
- ISIN
- CNE100005XG3
- Exchange
- Shanghai Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,827
- Fiscal year end
- December
- Address
- No. 258, Fengke Road, Shanghai, China
- Phone
- 86 21 6087 8333
- Website
- titansci.com
About Shanghai Titan Scientific Co. Ltd. A
Shanghai Titan Scientific Co., Ltd. provides laboratory products and supporting services for scientific researchers and quality control personnel. The company offers scientific research reagents, special chemicals, scientific research instruments and consumables, and laboratory construction and scientific research information services. It serves universities, hospitals, research institutes, government agencies, and R&D companies, as well as biopharmaceutical, pharmaceutical, materials, new energy, energy conservation and environmental protection, food and daily chemicals, analysis and testing, and intelligent manufacturing. The company was founded in 2007 and is headquartered in Shanghai, China.
Shanghai Titan Scientific Co. Ltd. A management
9- Mr. Qing ZhangGM, MD & Director · born 1983
- Mr. Zhihong ZhouAccounting Supervisor, Financial Controller & CFO · born 1977
- Mr. Gaoxiang DingDirector, Deputy GM, Board Secretary, Executive VP & COO · born 1982
- Mr. Hua ZhangDeputy GM & Director · born 1982
- Mr. Fengyuan XuDeputy GM of Supply Center & Director · born 1982
- Mr. Xiaowei ZhouVice President of Chemical Products · born 1983
- Mr. Liang GuEmployee Director & VP of Instrument Consumables Department · born 1984
- Mr. Wen Hui GeTechnical Director of Research & Information Technology Department · born 1982
- Mr. Ya Ping FanDirector of Laboratory Design & Construction · born 1983